Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Pierre Fabre Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (38)
Cancellation by sponsor (16)
Prescription medicine registration (3)
Australian Public Assessment Report (AusPAR) (1)
Designation or determination (1)

Date

2024 (3)
2023 (7)
2022 (10)
2021 (6)
2020 (10)
2019 (3)
2018 (2)
2017 (4)
2015 (4)
2005 (6)
2000 (2)
1998 (2)

Results for "[search-keyword]"

Search

Sponsor content

59 result(s) found, displaying 11 to 20

AusPAR: Levomilnacipran (as hydrochloride)

13 December 2016

Australian Public Assessment Report (AusPAR)

AusPAR: Levomilnacipran (as hydrochloride)
Eau Thermale Avene Summer Ready Pack (375232)

24 September 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Eau Thermale Avene Summer Ready Pack.
JONCIA milnacipran hydrochloride 100 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
JONCIA milnacipran hydrochloride 50 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
JONCIA milnacipran hydrochloride 50 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
JONCIA milnacipran hydrochloride 25 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
JONCIA milnacipran hydrochloride 25 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
Hemangiol-propranolol hydrochloride Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
JONCIA milnacipran hydrochloride 100 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
Pierre Fabre Australia Pty Ltd - Skin moisturizing/barrier dressing Cancelled under Section 41GL(d) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.